Sierra Oncology
Targeted Cancer Therapies using DNAi.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD368—552m (Dealroom.co estimates Apr 2014.)
Kalamazoo Michigan (HQ)
Financials
Estimates*
| EUR | 2015 |
|---|---|
| R&D budget | 24.0m |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
$780k | Seed | ||
$1.1m | Early VC | ||
$2.5m | Early VC | ||
$12.5m | Late VC | ||
| N/A | $1.7m | Early VC | |
| N/A | $4.3m | Debt | |
* | $59.5m | Series D | |
| N/A | $2.7m | Debt | |
| N/A | N/A | IPO | |
| N/A | $103m | Post IPO Equity | |
| N/A | $34.0m | Post IPO Equity | |
| N/A | $135m | Secondary | |
| Total Funding | AUD121m | ||
Related Content
Recent News about Sierra Oncology
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.